Pd. Ghys et al., Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Cote d'Ivoire, AIDS, 14(16), 2000, pp. 2603-2608
Objective: To detect anti-HIV antibodies in cervicovaginal secretions of HI
V-seronegative female sex workers and to evaluate whether the presence of t
hese antibodies is associated with increased sexual exposure.
Methods: A cross-sectional study was carried out at a confidential clinic f
or female sex workers in Abidjan, Cote d'Ivoire. The participants were 342
HIV-seronegative female sex workers in whom a cervicovaginal ravage was col
lected. The main outcome measures were the detection of antibodies to HIV-1
in cervicovaginal lavages using an in-house and a commercial (Seradyn Sent
inel(R); Calypte Biomedical Corporation, Berkeley, California, USA) enzyme
immunoassay; the detection of semen in cervicovaginal lavages; and the asse
ssment of epidemiological and biological markers of sexual exposure to HIV.
Results: Cervicovaginal anti-HIV antibodies were detected in 7.3 and 29.8%
of women using in-house enzyme-linked immunosorbent assay (ELISA) and Serad
yn Sentinel respectively. All cervicovaginal secretions found to be positiv
e by in-house ELISA were also positive by Seradyn Sentinel. In a minority o
f women, ranging from 2.9% by in-house ELISA to 12.3% by Seradyn Sentinel,
the anti-HIV antibodies were present in vaginal fluids that did not contain
semen. Sexual exposure to HIV was similar in women with anti-HIV antibodie
s in their semen-free cervicovaginal secretions compared with women without
anti-HIV antibodies in their cervicovaginal secretions.
Conclusions: Cervicovaginal HIV-specific antibodies were detected in a mino
rity of sexually exposed HIV-seronegative female sex workers in Abidjan. Th
e lack of association between increased sexual exposure to HIV and presence
of cervicovaginal HIV-specific antibodies suggests that the production of
genital HIV-specific antibodies in exposed seronegative women depends on th
e ability of individual women to mount specific mucosal immunity to HIV ant
igens, the determinants of which are currently unknown. (C) 2000 Lippincott
Williams & Wilkins.